E-LIB Suche - Ergebnisse für: Marquart, H. V.

1

ePS5.01 Cystic fibrosis (CF) patients chronically infected ..:

Lausen, M. ; Øbro, N.F. ; Nielsen, B.U....
Journal of Cystic Fibrosis. 21 (2022) - p. S55 , 2022

Link: https://doi.org/10.1016/..

2

Value of flow cytometry for MRD-based relapse prediction in..:

Modvig, S. ; Hallböök, H. ; Madsen, H. O....
Leukemia. 35 (2020) 7 - p. 1894-1906 , 2020

Link: https://doi.org/10.1038/..

3

T-cell acute lymphoblastic leukemia in patients 1–45 years ..:

Quist-Paulsen, P. ; Toft, N. ; Heyman, M....
Leukemia. 34 (2019) 2 - p. 347-357 , 2019

Link: https://doi.org/10.1038/..

4

Correction: Minimal residual disease quantification by flow..:

Modvig, S. ; Madsen, H. O. ; Siitonen, S. M....
Leukemia. 34 (2019) 6 - p. 1719-1720 , 2019

Link: https://doi.org/10.1038/..

5

Minimal residual disease quantification by flow cytometry p..:

Modvig, S. ; Madsen, H. O. ; Siitonen, S. M....
Leukemia. 33 (2018) 6 - p. 1324-1336 , 2018

Link: https://doi.org/10.1038/..

6

Results of NOPHO ALL2008 treatment for patients aged 1–45 y..:

Toft, N ; Birgens, H ; Abrahamsson, J...
Leukemia. 32 (2017) 3 - p. 606-615 , 2017

Link: https://doi.org/10.1038/..

7

Case Report: Renal Transplantation in Patients with Pre‐exi..:

Lund, K. P. ; Bruunsgaard, H. ; Marquart, H. V..
Scandinavian Journal of Immunology. 86 (2017) 2 - p. 113-117 , 2017

Link: https://doi.org/10.1111/..

8

Long-Term Follow-Up on Affinity Maturation and Memory B-Cel..:

Ballegaard, V. ; Permin, H. ; Katzenstein, T. L...
Journal of Clinical Immunology. 33 (2013) 6 - p. 1067-1077 , 2013

Link: https://doi.org/10.1007/..

9

Complement activation by malignant B cells from patients wi..:

Marquart, H V ; GrØNbÆEk, K ; Christensen, B E..
Clinical and Experimental Immunology. 102 (2008) 3 - p. 575-581 , 2008

Link: https://doi.org/10.1111/..

10

Complement receptor expression and activation of the comple..:

MARQUART, H V ; SVENDSEN, A ; RASMUSSEN, J M...
Clinical and Experimental Immunology. 101 (2008) 1 - p. 60-65 , 2008

Link: https://doi.org/10.1111/..

11

Complement‐activating ability of leucocytes from patients w..:

MARQUART*, H. V. ; RASMUSSEN, J. M. ; LESLIE, R. G. Q.
Immunology. 91 (1997) 3 - p. 486-492 , 1997

Link: https://doi.org/10.1046/..

12

A Comparative Study of Normal B Cells and the EBV‐Positive ..:

MARQUART, H. V. ; OLESEN, E. H. ; JOHNSON, A. A...
Scandinavian Journal of Immunology. 46 (1997) 3 - p. 246-253 , 1997

Link: https://doi.org/10.1046/..

13

Both HLA and mannan-binding lectin markers contribute to th..:

Garred, P. ; Madsen, H.O. ; Marquart, H....
Immunology Letters. 56 (1997) - p. 39-40 , 1997

Link: https://doi.org/10.1016/..

14

Value of flow cytometry for MRD-based relapse prediction in..:

Modvig, S ; Hallböök, H ; Madsen, H. O...
10.1038/s41375-020-01100-5. , 2023

Link: http://hdl.handle.net/10..

15

Value of flow cytometry for MRD-based relapse prediction in..:

Modvig, S ; Hallböök, Helene ; Madsen, H. O...
Leukemia, 0887-6924, 2021, 35:7, s. 1894-1906. , 2021

Link: http://urn.kb.se/resolve..